Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The present study aimed to evaluate the effect of rosiglitazone treatment on cardiac function compared with metformin

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Baskent University
• Treatments: Rosiglitazone

Criteria

Inclusion Criteria:

• Type 2 diabetes mellitus treated with oral hypoglycemic agents or diet only

• Without any symptom or finding of heart failure

• Normal liver enzymes and renal functions

Exclusion Criteria:

• Any known coronary artery disease, congestive hearth failure, renal disease or liver disease

• Any treatment for heart failure or diuretics for any reasons.